pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,781 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×type: approval×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07427225: Dual-Task vs. Multicomponent Exercise in Institutionalized Seniors

    Sponsor: Instituto Politécnico de Leiria. Phase: NA. Conditions: Fear of Falling

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05111925: Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement

    Sponsor: Womack Army Medical Center. Phase: . Conditions: Musculoskeletal Injuries

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528625: Behavioral Interventions as Primary Prevention for Non-Communicable Diseases Among Young People

    Sponsor: Deraya University. Phase: NA. Conditions: Non Communicable Diseases, Non Communicable Chronic Diseases

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03329976: Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Surgery for Cataract, Surgery for and Idiopathic Epiretinal Membrane

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06842576: Health Care Transition Readiness Short-Form Video Intervention

    Sponsor: Children's Hospital Los Angeles. Phase: NA. Conditions: Health Care Transition Readiness, Health Literacy, Self Efficacy, Emotional Wellbeing, Appointment Attendance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06108076: Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: EARLY_PHASE1. Conditions: Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04171817: Animal-Assisted Visitation Program Chlorhexidine Trial

    Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: PHASE4. Conditions: Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, Pseudomonas Aeruginosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07124117: A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

    Sponsor: OBI Pharma, Inc. Phase: PHASE1. Conditions: Advanced Solid Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01859117: Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers

    Sponsor: Celularity Incorporated. Phase: PHASE1. Conditions: Peripheral Arterial Disease, Diabetic Foot Ulcer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05555940: Effect of Individualized Precise TMS on Emotional Blunting in Depression and Its Brain Imaging Mechanism

    Sponsor: Xijing Hospital. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05355389: Cognitive-motor Telerehabilitation in MS

    Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07319468: Effect of Exercises on Hemodialysis

    Sponsor: Cairo University. Phase: NA. Conditions: Hemodialytic Patients

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03721068: Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: PHASE1. Conditions: Neuroblastoma, Osteosarcoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03898206: Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults

    Sponsor: University of Bedfordshire. Phase: NA. Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases, Diabetes, Physical Activity, Sedentary Lifestyle

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07177404: Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

    Sponsor: University of Nottingham. Phase: . Conditions: Diabete Mellitus, Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07662304: Effect of Continuous Supraglottic Oxygen Insufflation Via Video Laryngoscope Blade on Apneic Oxygenation During Tracheal Intubation Under General Anesthesia

    Sponsor: Affiliated Hospital of Jiaxing University. Phase: NA. Conditions: Apneic Oxygenation

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06106204: Reducing Overuse of Antibiotics at Discharge Home

    Sponsor: University of Utah. Phase: NA. Conditions: Pneumonia, Urinary Tract Infection, Antibiotic Stewardship, Care Transition

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05794204: RMP-A03 Ocular Suspension in Patients With Pterygium

    Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.. Phase: PHASE2. Conditions: Pterygium

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Lung Diseases, Interstitial

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06931652: Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

    Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Primary CNS Lymphoma (PCNSL)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06849752: Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF

    Sponsor: The Cleveland Clinic. Phase: . Conditions: Heart Failure, Socioeconomic Adversity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07398352: Comparison Of The Effects Of Regional Anesthesia On Brain And Carotid Artery Oxygenation In Shoulder Surgery

    Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital. Phase: NA. Conditions: Interscalene Block, Superficial Cervical Block, Cerebral Perfusion, Shoulder Surgeries

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05880849: Choline Effects - Pre-symptomatic AD

    Sponsor: Paul E Schulz. Phase: PHASE1. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06694584: Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention

    Sponsor: Catholic University of Applied Sciences Mainz. Phase: NA. Conditions: Resilience, Psychological, Personnel, Hospital

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07594938: Studying Fatigue and Movement After Stroke

    Sponsor: Vrije Universiteit Brussel. Phase: . Conditions: Stroke, Cerebro-vascular Accident, Ischemia Stroke, Hemorrhage Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05833438: Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

    Sponsor: University of Leipzig. Phase: PHASE2. Conditions: Acute Myeloid Leukemia (AML)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03447938: The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05934838: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06788938: Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE2. Conditions: DLL3-expressing Tumors, Advanced Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06842238: Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation

    Sponsor: Elsan. Phase: . Conditions: Bronchiolitis, Bronchiolitis Acute

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01274338: Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06983158: A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

    Sponsor: Capsida Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Developmental and Epileptic Encephalopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07308158: Covid Flu A/B and RSV 4 in 1 Diagnostic Test

    Sponsor: iHealth Labs inc. Phase: . Conditions: Influenza A, Influenza B, COVID - 19, RSV

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06697158: Investigation of the Effects of Complex Decongestive Physiotherapy on Sleep Quality and Quality of Life in Women With Breast Cancer Related Lymphedema

    Sponsor: Abant Izzet Baysal University. Phase: NA. Conditions: Breast Cancer Related Lymphedema

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07591948: The Effect of Low-Level Laser Therapy on Accelerating Tooth Movement and Reducing Pain During Orthodontic Treatment

    Sponsor: Sana'a University. Phase: NA. Conditions: Acceleration of Tooth Movement

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05003648: Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

    Sponsor: Massachusetts General Hospital. Phase: PHASE4. Conditions: Adrenoleukodystrophy, Restless Legs Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07664748: Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

    Sponsor: Niguarda Hospital. Phase: NA. Conditions: Heart Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06669455: An Integrated and Personalized Lifestyle Approach for People With Parkinson's Disease

    Sponsor: Radboud University Medical Center. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04221555: Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma

    Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06867055: Evaluation of the Effectiveness of Different Procedures on Palatinal Wound Healing After Free Gingival Graft Surgery.

    Sponsor: SEVAL CEYLAN ŞEN. Phase: NA. Conditions: Insufficient Keratinized Gingiva

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07397026: Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial

    Sponsor: Hagar Ahmed Ali Mohammed Elzain. Phase: PHASE1. Conditions: Periodontitis Stage III

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07478926: Flow Detection in Open and Closed Shunt Valve Periods

    Sponsor: Rhaeos, Inc.. Phase: NA. Conditions: Hydrocephalus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06044285: Ultra Crave: An Investigation of Ultra-Processed Food

    Sponsor: University of Michigan. Phase: NA. Conditions: Food Addiction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06809543: Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy

    Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Rotator Cuff Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06788743: Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial

    Sponsor: Xijing Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Diabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07582770: Cognitive Impairment Assessment in Breast Cancer Survivors

    Sponsor: European Institute of Oncology. Phase: . Conditions: Cancer Related Cognitive Impairment, Breast Cancer Survivors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07381569: To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion

    Sponsor: Peking Union Medical College Hospital. Phase: NA. Conditions: Abortion, Induced

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07364669: Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects

    Sponsor: Laboratorios Pisa S.A. de C.V.. Phase: PHASE1. Conditions: Healthy Subjects

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04189783: Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Retroperitoneal Sarcoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06408441: The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

    Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano. Phase: . Conditions: Epithelioid Hemangioendothelioma, Sarcoma,Soft Tissue

    full page →ctgov ↗
    ← prev
    page 67 of 96
    next →